Article Commentary: Further Research Needed to Support a Policy of Antiretroviral Therapy as An HIV Prevention Initiative

Alison Rodger(Royal Free London NHS Foundation Trust), Vicente Estrada(Instituto de Salud Carlos III), Giulio Maria Corbelli(Associazione Italiana Vulvodinia Onlus), Simon Collins(Ghent University Hospital), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Pietro Vernazza(University of Zurich), Jan van Lunzen(Universidade Federal de São Paulo), Andrew Phillips(Wake Forest University), Tina Bruun(University of Copenhagen)

Antiviral Therapy

April 1, 2013

10.3851/imp2609

Cited by 8

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

|The Lancet|2003|1.2k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

|Journal of Clinical Oncology|2010|1k

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

|AIDS|2003|987